White or almost white, fine crystalline powder.
5-HT receptor antagonist; partial agonist at adrenergic and dopaminergic receptors
4,10-Dihydroergocristine Methanesulfonate is an nontoxic and well tolerated drug that exerts agonistic and antagonistic activity on dopaminergic and adrenergic receptors. 4,10-Dihydroergocristine Meth
anesulfonate is known to exhibit protective properties to the brain against metabolic effects of ischemia by acting at a cellular level.
ChEBI: The methanesulfonic acid salt of dihydroergocristine. It has been used as the for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease. It is also a component of ergoloid mesylat
(codergocrine mesilate), a mixture of ergot alkaloid derivatives that is used as a vasodilator and has shown mild benefits in the treatment of vascular dementia.
5-HT receptor antagonist; partial agonist at adrenergic and dopaminergic receptors.